Brain tumour genetic network signatures of survival
Authors:
- James K RuffleJRJames K Ruffle
- Robert GrayRGRobert Gray
- Parashkev NachevPNParashkev Nachev
Preprint
Abstract
Tumour heterogeneity is increasingly recognized as a major obstacle to therapeutic success across neuro-oncology. Gliomas are characterised by distinct combinations of genetic and epigenetic alterations, resulting in complex interactions across multiple molecular pathways. Predicting disease evolution and prescribing individually optimal treatment requires statistical models complex enough to capture the intricate (epi)genetic structure underpinning oncogenesis. Here, we formalize this task as the inference of distinct patterns of connectivity within hierarchical latent representations of genetic networks. Evaluating multi-institutional clinical, genetic, and outcome data from 4023 glioma patients over 14 years, across 12 countries, we employ Bayesian generative stochastic block modelling to reveal a hierarchical network structure of tumour genetics spanning molecularly confirmed glioblastoma, IDH- wildtype; oligodendroglioma, IDH-mutant and 1p/19q codeleted; and astrocytoma, IDH- mutant. Our findings illuminate the complex dependence between features across the genetic landscape of brain tumours, and show that generative network models reveal distinct signatures of survival with better prognostic fidelity than current gold standard diagnostic categories.Keywords
All Related Versions
This publication has 107 references indexed in Scilit:
- The role of deep learning‐based survival model in improving survival prediction of patients with glioblastomaCancer Medicine, 2021
- cIMPACT-NOW update 3: recommended diagnostic criteria for “Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV”Acta Neuropathologica, 2018
- Novel, improved grading system(s) for IDH-mutant astrocytic gliomasActa Neuropathologica, 2018
- Neurological update: gliomas and other primary brain tumours in adultsJournal of Neurology, 2017
- BRAF V600E mutations are frequent in dysembryoplastic neuroepithelial tumors and subependymal giant cell astrocytomasJournal of Surgical Oncology, 2014
- High intratumor genetic heterogeneity is related to worse outcome in patients with head and neck squamous cell carcinomaCancer, 2013
- Molecular pathogenesis of IDH mutations in gliomasBrain Tumor Pathology, 2012
- Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytomaActa Neuropathologica, 2011
- Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomasActa Neuropathologica, 2009
- MGMT promoter methylation correlates with survival benefit and sensitivity to temozolomide in pediatric glioblastomaPediatric Blood & Cancer, 2007